| Serial Number | 98428094 |
| Word Mark | CANNOVATION |
| Filing Date | Thursday, February 29, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, December 22, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Business consulting and process assessment services in the nature of Business planning, Clinical trial design and administration, DEA and FDA Regulatory Consulting, Supply development, project management, commercialization strategies in the field of prescription and non-prescription drugs and products; business consulting relating to regulatory compliance, namely providing guidance and recommending resources to assist with regulatory and legal issues; consulting services to assist drug and non-drug companies in the field of business and program management; business planning; Business planning in the field of distribution and product distribution management; business consulting services in the field of government and regulatory compliance; business services in the field of regulatory compliance strategy, namely develop and provide regulatory strategy; business services in the fields of goods or services sourcing, supply chain management; business services namely, importation and exportation product sourcing and logistics guidance; business services, namely coordinating the activities and supply chain of national and internation FDA registered drug, API and excipient manufacturers in the fields of international and domestic market entry; and business consulting, management and planning in the field of Medical device, pharmaceutical and nutraceutical product development and clinical research. |
| Goods and Services | Product licensing; and product licensing consultancy relating to licensing pharmaceuticals and non-drug products. |
| Goods and Services | Clinical research, consulting, analysis and study services in the field of drug evaluation; clinical research consulting services in the field of pharmaceuticals; and clinical research consulting and advisory services related to ensuring the safety of pharmaceutical preparations. |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 29, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Tuesday, February 6, 2024 |
| First Use In Commerce Date | Tuesday, February 6, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, February 6, 2024 |
| First Use In Commerce Date | Tuesday, February 6, 2024 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 29, 2024 |
| Primary Code | 045 |
| First Use Anywhere Date | Tuesday, February 6, 2024 |
| First Use In Commerce Date | Tuesday, February 6, 2024 |
| Party Name | CCR Partners, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Buford, GA 30519 |
| Event Date | Event Description |
| Thursday, February 29, 2024 | NEW APPLICATION ENTERED |
| Friday, July 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 12, 2025 | ASSIGNED TO EXAMINER |
| Friday, November 21, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, November 21, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, November 21, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 22, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 22, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 22, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |